Gossamer Bio Inc (US: GOSS) — Healthcare · Share Price, Chart & Market Data
About: Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.35 (-4.66%)
GOSSGossamer Bio Inc
Loading watchlist status…
Trade GOSS now
Gossamer Bio Inc share price
GOSS price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 8:12 pm GMT+0
GOSS price performance
-8.373%
5D
-0.346%
1M
-87.993%
YTD
-60.543%
1Y
GOSS price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 8:12 pm GMT+0
GOSS details
GOSS Market Signals